The literature surrounding measurement of plasma OXT concentrations in Prader–Willi syndrome is conflicting, with some authors finding it is decreased relative to the degree of obesity, while others have reported that both plasma and cerebrospinal fluid OXT is increased (451, 454, 455). The gene discussed is OXT; the disease is obesity disorder.